ProKidney Corp - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: ProKidney Corp - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: ProKidney Corp - Ordinary Shares - Class A
Rating: 1.58650
Author: Trendlyne DVM scores

about

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

2.59 0.03 (1.17%)

63.67% Fall from 52W High

2.3M

XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.5 / 100

Technically Moderately Bullish

63.0 / 100

1Yr Price target upside is 116%

5 analysts

ProKidney Corp - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ProKidney Corp - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

63.67% Fall from 52W High

SWOT Analysis

ProKidney Corp - Ordinary ... Live Price Chart